Category: Antibody Technologies
Antibody Technologies market research reports by DelveInsight
-
Anti-CD28 Antibody - Pipeline Insight, 2022
“ Anti-CD28 Antibody - Pipeline Insight, 2022 ” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Anti-CD28 Antibody development. The report provides detailed coverage of the pipeline landscape for this mechanis ... Read More
-
Anti-CD279 (PD-1) Antibody - Pipeline Insight, 2022
“ Anti-CD279 (PD-1) Antibody - Pipeline Insight, 2022 ” report provides comprehensive insights about 40+ companies and 40+ pipeline drugs in Anti-CD279 (PD-1) Antibody pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the ther ... Read More
-
Anti-CD3 Antibody - Pipeline Insight, 2022
“ Anti-CD3 Antibody - Pipeline Insight, 2022 ” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Anti-CD3 Antibody development. The report provides detailed coverage of the pipeline landscape for this mechanism ... Read More
-
Graft Versus Host Disease (GvHD) - Market Insight, Epidemiology and Market Forecast -2032
DelveInsight's "" Graft Versus Host Disease (GvHD)- Market Insights, Epidemiology, and Market Forecast-2032 "" report delivers an in-depth understanding of the Graft Versus Host Disease (GvHD), historical and forecasted epidemiology as well as the Graft Versus Host Disease (GvHD) market trends in th ... Read More
-
CD137 Agonist Antibody - Pipeline Insight, 2022
“ CD137 Agonist Antibody - Pipeline Insight, 2022 ” report provides comprehensive insights about 15+ companies and 15+ pipeline drugs in CD137 Agonist Antibody pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics ... Read More
-
Anti-Mucin 1 (MUC1) Antibody - Pipeline Insight, 2022
“ Anti-Mucin 1 (MUC1) Antibody - Pipeline Insight, 2022 ” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Anti-Mucin 1 (MUC1) Antibody development. The report provides detailed coverage of the pipeline landsca ... Read More
-
Immunoglobulin inhibitors - Pipeline Insight, 2022
“ Immunoglobulin inhibitors - Pipeline Insight, 2022 ” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Immunoglobulin inhibitors pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeu ... Read More
-
Anti-CD52 Antibody - Pipeline Insight, 2022
“ Anti-CD52 Antibody - Pipeline Insight, 2022 ” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Anti-CD52 Antibody development. The report provides detailed coverage of the pipeline landscape for this mechanis ... Read More
-
Anti GM-CSF Antibody - Pipeline Insight, 2022
“ Anti GM-CSF Antibody - Pipeline Insight, 2022 ” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Anti GM-CSF Antibody development. The report provides detailed coverage of the pipeline landscape for this mech ... Read More
-
Anti-CD33 Antibody - Pipeline Insight, 2022
“ Anti-CD33 Antibody - Pipeline Insight, 2022 ” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Anti-CD33 Antibody development. The report provides detailed coverage of the pipeline landscape for this mechanis ... Read More
-
Biologics - Market Insights, Competitive Landscape and Market Forecast–2026
Biologics - Market Insights, Competitive Landscape and Market Forecast–2026 Biologics Market By Product Type (Cell-Based Biologics, Gene-Based Biologics, Monoclonal Antibodies, Vaccines, Recombinant Protiens, And Others), By Application (Oncology, Immunology, Infectious Diseases, Neurological Diseas ... Read More
-
Graft Versus Host Disease (GvHD) - Epidemiology Forecast to 2032
DelveInsight's "" Graft Versus Host Disease (GvHD) - Epidemiology Forecast to 2032 "" report delivers an in-depth understanding of the disease, historical and forecasted Graft Versus Host Disease (GvHD) epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the Uni ... Read More
-
Guillain-Barre Syndrome (GBS) - Epidemiology Forecast to 2032
DelveInsight's "" Guillain-Barre Syndrome (GBS) - Epidemiology Forecast to 2032 "" report delivers an in-depth understanding of the disease, historical and forecasted Guillain-Barre Syndrome (GBS) epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Ki ... Read More
-
Cytokine Release Syndrome (CRS)-Epidemiology Forecast–2032
DelveInsight's "" Cytokine Release Syndrome (CRS) - Epidemiology Forecast to 2032 "" report delivers an in-depth understanding of the disease, historical and forecasted Cytokine Release Syndrome (CRS) epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the Unite ... Read More
-
MOG Antibody Disease - Epidemiology Forecast - 2032
DelveInsight's "" MOG Antibody Disease - Epidemiology Forecast to 2032 "" report delivers an in-depth understanding of the disease, historical and forecasted MOG Antibody Disease epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. ... Read More
-
Anti-CD40 Antibody - Pipeline Insight, 2022
“ Anti-CD40 Antibody - Pipeline Insight, 2022 ” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Anti-CD40 Antibody development. The report provides detailed coverage of the pipeline landscape for this mechanis ... Read More
-
Anti-CD152 Antibody - Pipeline Insight, 2022
“ Anti-CD152 Antibody - Pipeline Insight, 2022 ” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Anti-CD152 Antibody development. The report provides detailed coverage of the pipeline landscape for this mechan ... Read More
-
Anti-CD37 Antibody - Pipeline Insight, 2022
“ Anti-CD37 Antibody - Pipeline Insight, 2022 ” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Anti-CD37 Antibody development. The report provides detailed coverage of the pipeline landscape for this mechanis ... Read More
-
Dense Deposit Disease - Epidemiology Forecast - 2032
DelveInsight's "" Dense Deposit Disease - Epidemiology Forecast to 2032 "" report delivers an in-depth understanding of the disease, historical and forecasted Dense Deposit Disease epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japa ... Read More
Research Assistance
